Cargando…

The Clinical Impact of Recombinant Human Erythropoietin

Detalles Bibliográficos
Autor principal: Muirhead, N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royal College of Physicians of London 1997
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5420899/
https://www.ncbi.nlm.nih.gov/pubmed/9131506
_version_ 1783234490536034304
author Muirhead, N
author_facet Muirhead, N
author_sort Muirhead, N
collection PubMed
description
format Online
Article
Text
id pubmed-5420899
institution National Center for Biotechnology Information
language English
publishDate 1997
publisher Royal College of Physicians of London
record_format MEDLINE/PubMed
spelling pubmed-54208992019-01-22 The Clinical Impact of Recombinant Human Erythropoietin Muirhead, N J R Coll Physicians Lond CME — Renal Disease (II) Royal College of Physicians of London 1997 /pmc/articles/PMC5420899/ /pubmed/9131506 Text en © Journal of the Royal College of Physicians of London 1997 http://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) , which permits non-commercial use and redistribution provided that the original author and source are credited.
spellingShingle CME — Renal Disease (II)
Muirhead, N
The Clinical Impact of Recombinant Human Erythropoietin
title The Clinical Impact of Recombinant Human Erythropoietin
title_full The Clinical Impact of Recombinant Human Erythropoietin
title_fullStr The Clinical Impact of Recombinant Human Erythropoietin
title_full_unstemmed The Clinical Impact of Recombinant Human Erythropoietin
title_short The Clinical Impact of Recombinant Human Erythropoietin
title_sort clinical impact of recombinant human erythropoietin
topic CME — Renal Disease (II)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5420899/
https://www.ncbi.nlm.nih.gov/pubmed/9131506
work_keys_str_mv AT muirheadn theclinicalimpactofrecombinanthumanerythropoietin
AT muirheadn clinicalimpactofrecombinanthumanerythropoietin